Published in Crit Care Med on October 01, 2012
How about the impact of treatment on procalcitonin dynamics? Crit Care Med (2013) 1.06
Changes in circulating procalcitonin versus C-reactive protein in predicting evolution of infectious disease in febrile, critically ill patients. PLoS One (2013) 0.93
The many facets of procalcitonin in the critically ill population. Crit Care Med (2012) 0.77
The authors reply. Crit Care Med (2013) 0.75
Intensive versus conventional glucose control in critically ill patients. N Engl J Med (2009) 26.30
A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med (2013) 8.94
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis (2012) 7.97
Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ (2009) 6.27
Hypoglycemia and risk of death in critically ill patients. N Engl J Med (2012) 6.17
Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations. Crit Care Med (2006) 4.85
Toothbrushing for critically ill mechanically ventilated patients: a systematic review and meta-analysis of randomized trials evaluating ventilator-associated pneumonia. Crit Care Med (2013) 4.29
Meta-analysis: outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography. Ann Intern Med (2004) 3.97
Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis (2008) 3.88
Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*. Crit Care Med (2012) 3.86
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis (2011) 3.20
Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care Med (2011) 3.14
The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med (2009) 3.11
Patient and healthcare professional factors influencing end-of-life decision-making during critical illness: a systematic review. Crit Care Med (2011) 3.07
Blood transfusion and nosocomial infection: another brick in the wall. Crit Care Med (2006) 3.00
The Very Elderly Admitted to ICU: A Quality Finish? Crit Care Med (2015) 2.77
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest (2006) 2.73
Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study). Intensive Care Med (2014) 2.70
Nutritional practices and their relationship to clinical outcomes in critically ill children--an international multicenter cohort study*. Crit Care Med (2012) 2.53
Multicentre, cluster-randomized clinical trial of algorithms for critical-care enteral and parenteral therapy (ACCEPT). CMAJ (2004) 2.45
Growth in adult prolonged acute mechanical ventilation: implications for healthcare delivery. Crit Care Med (2008) 2.43
Probiotics in the critically ill: a systematic review of the randomized trial evidence. Crit Care Med (2012) 2.35
Refinement, scoring, and validation of the Family Satisfaction in the Intensive Care Unit (FS-ICU) survey. Crit Care Med (2007) 2.34
Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidence. Crit Care Med (2002) 2.34
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med (2011) 2.27
Ethical assessment of industry-sponsored clinical trials: a case analysis. Chest (2002) 2.27
Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med (2002) 2.24
Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest (2013) 2.24
Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME). Transfusion (2010) 2.24
Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest (2005) 2.20
A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit Care Med (2009) 2.17
Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. Crit Care Med (2015) 2.16
Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med (2005) 2.12
Factors associated with acute lung injury in combat casualties receiving massive blood transfusions: a retrospective analysis. J Crit Care (2012) 2.09
Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. Chest (2009) 2.09
Nutrition therapy in the critical care setting: what is "best achievable" practice? An international multicenter observational study. Crit Care Med (2010) 2.02
Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit Care Med (2011) 1.98
Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med (2004) 1.97
Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition (2004) 1.94
Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med (2008) 1.94
Extreme obesity and outcomes in critically ill patients. Chest (2011) 1.92
Nutrition support in acute pancreatitis: a systematic review of the literature. JPEN J Parenter Enteral Nutr (2006) 1.84
Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect (2010) 1.83
Perioperative use of arginine-supplemented diets: a systematic review of the evidence. J Am Coll Surg (2011) 1.82
Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? Chest (2010) 1.81
Understanding adherence to guidelines in the intensive care unit: development of a comprehensive framework. JPEN J Parenter Enteral Nutr (2010) 1.78
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med (2013) 1.74
Translating family satisfaction data into quality improvement. Crit Care Med (2004) 1.68
Implementation of clinical practice guidelines for ventilator-associated pneumonia: a multicenter prospective study. Crit Care Med (2013) 1.68
The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients. J Crit Care (2008) 1.67
Early use of supplemental parenteral nutrition in critically ill patients: results of an international multicenter observational study. Crit Care Med (2011) 1.64
Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients. Crit Care (2013) 1.62
Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med (2014) 1.61
Defining priorities for improving end-of-life care in Canada. CMAJ (2010) 1.59
Accuracy of previous estimates for adult prolonged acute mechanical ventilation volume in 2020: update using 2000-2008 data. Crit Care Med (2012) 1.57
A multicenter, randomized controlled trial comparing early nasojejunal with nasogastric nutrition in critical illness. Crit Care Med (2012) 1.57
Enhanced protein-energy provision via the enteral route feeding protocol in critically ill patients: results of a cluster randomized trial. Crit Care Med (2013) 1.57
Knowledge translation interventions for critically ill patients: a systematic review*. Crit Care Med (2013) 1.53
The Association Between Nutritional Adequacy and Long-Term Outcomes in Critically Ill Patients Requiring Prolonged Mechanical Ventilation: A Multicenter Cohort Study. Crit Care Med (2015) 1.52
The relationship between organizational culture and family satisfaction in critical care. Crit Care Med (2012) 1.52
Comparisons between intragastric and small intestinal delivery of enteral nutrition in the critically ill: a systematic review and meta-analysis. Crit Care (2013) 1.51
Prolonged acute mechanical ventilation, hospital resource utilization, and mortality in the United States. Crit Care Med (2008) 1.50
Interferon gamma-1b as therapy for idiopathic pulmonary fibrosis. An intrapatient analysis. Respiration (2004) 1.48
Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest (2008) 1.47
Epidemiology and outcomes of clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. Chest (2009) 1.47
Guidelines, guidelines, guidelines: what are we to do with all of these North American guidelines? JPEN J Parenter Enteral Nutr (2010) 1.47
The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated. Chest (2013) 1.46
Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009. Infect Control Hosp Epidemiol (2013) 1.45
Toward optimal end-of-life care for patients with advanced chronic obstructive pulmonary disease: insights from a multicentre study. Can Respir J (2008) 1.45
Bridging the guideline-practice gap in critical care nutrition: a review of guideline implementation studies. JPEN J Parenter Enteral Nutr (2010) 1.45
Unnecessary use of placebo controls: the case of asthma clinical trials. Arch Intern Med (2002) 1.44
The effects of different IV fat emulsions on clinical outcomes in critically ill patients. Crit Care Med (2014) 1.44
Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis. Respiration (2004) 1.44
Duration of Antimicrobial Treatment for Bacteremia in Canadian Critically Ill Patients. Crit Care Med (2016) 1.44
Attitudes and beliefs related to the Canadian critical care nutrition practice guidelines: an international survey of critical care physicians and dietitians. JPEN J Parenter Enteral Nutr (2010) 1.43
The Role for Optical Density in Heparin-Induced Thrombocytopenia: A Cohort Study. Chest (2015) 1.43
Secular trends in candidemia-related hospitalization in the United States, 2000-2005. Infect Control Hosp Epidemiol (2008) 1.42
Pharmaconutrition with arginine decreases bacterial translocation in an animal model of severe trauma. Is a clinical studied justified? .... The time is now! Crit Care Med (2012) 1.42
Psychometric evaluation of a modified version of the family satisfaction in the ICU survey in parents/caregivers of critically ill children*. Pediatr Crit Care Med (2013) 1.40
Mechanism of injury influences quality of life in survivors of acute respiratory distress syndrome. Intensive Care Med (2006) 1.39
Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Crit Care (2011) 1.38
Nutrition support in mechanically ventilated, critically ill adult patients: are we ready for evidence-based clinical practice guidelines? Nutr Clin Pract (2004) 1.38
North American Summit on Aspiration in the Critically Ill Patient: consensus statement. JPEN J Parenter Enteral Nutr (2002) 1.37
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis (2010) 1.29
The development and validation of a novel questionnaire to measure patient and family satisfaction with end-of-life care: the Canadian Health Care Evaluation Project (CANHELP) Questionnaire. Palliat Med (2010) 1.26
Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy (2010) 1.25
FDA guidance for ABSSSI trials: implications for conducting and interpreting clinical trials. Clin Infect Dis (2014) 1.25